缺氧诱导的circMYH9通过ATF4调控结直肠癌干性和化疗敏感性的作用和机制研究
批准号:
82072729
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
张易
依托单位:
学科分类:
肿瘤治疗抵抗
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
张易
中文摘要
既往研究证实,缺氧能增强结直肠癌(CRC)干性并抑制其化疗敏感性。而circRNA在其中的作用则未见报道。我们发现:内含子来源的circMYH9在上述过程中发挥关键作用,HIF-1α和ATF4是其上下游调控分子。circMYH9调控ATF4依赖于抑制hnRNPC与ATF4前体RNA m6A位点结合;ATF4具有招募KMT2b在转录水平增强干性标志分子表达功能。据此提出假说:缺氧通过HIF-1α介导circMYH9升高,circMYH9通过ATF4调控CRC干性和化疗敏感性。拟开展:①研究缺氧下circMYH9的功能与表达升高原因,从m6A修饰和组蛋白甲基化修饰角度研究circMYH9通过ATF4调控干性标志分子的机制;②评估裸鼠体内抑制circMYH9的治疗效果;③在CRC组织中研究上述分子的临床意义。本研究从circRNA角度为缺氧促进CRC发展的机制研究和阻断治疗提供了新思路和新靶点。
英文摘要
Previous studies have confirmed that hypoxia can enhance the stemness of colorectal cancer (CRC) and inhibit its chemotherapy sensitivity. The role of circRNA in the above process has not been reported. We found that intron-derived circMYH9 plays a key role in the above process, and HIF-1α and ATF4 are its upstream and downstream regulatory molecules. CircMYH9 regulating ATF4 depends on inhibiting the binding of hnRNPC to the m6A site of ATF4 precursor RNA; ATF4 recruits KMT2b to enhance the expression of stem marker molecules at the transcription level. Accordingly raise the hypothesis: hypoxia mediates the increase of circMYH9 through HIF-1α, and circMYH9 regulates CRC stemness and chemotherapy sensitivity through ATF4. To be carried out: ① To study the function of circMYH9 and the cause leading to its overexpression under hypoxia, and to study the mechanism of circMYH9's regulation of stemness markers through ATF4 from the perspective of m6A modification and histone methylation modification; ② To evaluate the therapeutic effect of inhibiting circMYH9 in nude mice;③ To study the clinical significance of the above molecules in CRC tissues. From the perspective of circRNA, this study provides new ways for the study of the mechanism of hypoxia to promote CRC and new targets for the blocking treatment.
缺氧是实体肿瘤进展中的重要因素,会导致癌症相关环状RNA(circRNA)的异常表达,从而调控多种细胞过程。然而,circRNA在缺氧条件下如何影响结直肠癌(CRC)的干性和化疗敏感性仍不明确。本研究聚焦circMYH9,探讨其在缺氧环境中的作用及分子机制。研究内容:检测circMYH9在CRC细胞系中的表达水平及缺氧条件对其影响。通过沉默或过表达circMYH9,评估其对CRC干性及化疗敏感性的调控作用。研究缺氧诱导HIF-1α是否通过结合MYH9启动子促进circMYH9表达,并筛选circMYH9的关键靶基因和潜在调控因子。探索circMYH9通过RNA结合蛋白hnRNPC影响靶基因ATF4的表达机制。重要结果:在缺氧条件下,沉默circMYH9降低了CRC细胞干性标志分子(CD133、SOX2、LGR5)的表达,增强化疗敏感性。过表达circMYH9则增强干性并进一步抑制化疗敏感性。动物实验证实:circMYH9沉默显著降低肿瘤发生率和干细胞比例。HIF-1α在缺氧下富集于MYH9启动子区域,促进circMYH9生成。ATF4为circMYH9的关键靶基因。沉默ATF4抑制CRC干性并提高化疗敏感性,而过表达ATF4可逆转circMYH9沉默引起的干性下降。circMYH9通过hnRNPC正向调控ATF4 mRNA稳定性和蛋白表达。hnRNPC沉默可减少ATF4的稳定性和水平,而过表达可部分恢复circMYH9沉默引起的影响。科学意义:本研究揭示了缺氧诱导的circMYH9在CRC中的重要作用,提供了circRNA如何调控肿瘤干性和化疗敏感性的分子机制。这一发现有助于进一步理解CRC在缺氧条件下的进展机制,并为开发新型抗癌治疗策略(如靶向circMYH9或其相关通路)提供了理论依据。
miR-506通过BMP-4逆转结直肠癌干细胞干性研究
-
批准号:81702435
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:张易
-
依托单位:
国内基金
海外基金